Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
New insights into advanced bladder cancer
First-of-its-kind rapid autopsy program helps reveal deadly disease’s potential vulnerabilities
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Path to a targeted treatment for small-cell lung cancer?
Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
MERGE improves precision medicine for acute myeloid leukemia
from Dr. Pamela Becker, Clinical Research Division
A roadmap for precision colorectal cancer screening
New study combines environmental, lifestyle and genetic information to create a more nuanced risk-prediction model
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology
Good News: $1.8M Cancer Moonshot grant advances precision medicine for pancreatic cancer
Celebrating faculty and staff achievements
Q & A with Dr. Peggy Porter: Targeted breast cancer treatments require diverse research data
Breast cancer researcher discusses need to extend research and results to minority women
The path to precision screening for cancer
For now, early detection of breast and prostate cancer means mammograms and PSAs, but a more tailored approach is on the horizon
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Aspirin and its cousins linked to longer survival after colorectal cancer
Large study of preventive drugs for colorectal cancer survivors finds link to decreased mortality — but only for those with certain tumor genetics
5 highlights from American Association for Cancer Research conference
Immunotherapy, health disparities, funding cuts among hot topics at annual meeting
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
.jpg)
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis
'Kids are not little adults'
Why children with cancer need their own drugs and their own research
A new model for pancreatic cancer research: Flexible, precision-medicine trial 'driven by doing what is best for the individual patient'
Flexible, precision-medicine trial ‘driven by doing what is best for the individual patient’
Big takeaways from ASCO cancer conference: immunotherapy, precision medicine and more
Immunotherapy, precision medicine and patient-powered research among the highlights of the world’s largest cancer conference
Fred Hutch president elected to American Academy of Arts & Sciences
Dr. Gary Gilliland named as new member of country’s oldest learned societies